Stock Events

Stock Events

Spero Therapeutics (2HA.F) Q2 2025 Earnings

13MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.49

-0.4

-0.31

-0.22

Details

Expected EPS

-0.49149650000000006

Actual EPS

-0.2234075

Surprise EPS

0.27

Surprise Percent

+54.55%

Description

Spero Therapeutics (2HA.F) has reported earnings of -0.2234075 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.